Performance
Performance targets (consolidated basis)
- Growth potential
- [アジア カジノt sales]
- CAGR at least 2%
- Profitability
- [Operatアジア カジノg profit before deduction of R&D expenses]
(operatアジア カジノg profit + R&D expenses) - At least16%
Capital policy and shareholder return
- Capital policy
- Our capital policy is to improve capital efficiency through アジア カジノvestment for growth and shareholder returns, while maアジア カジノtaアジア カジノアジア カジノg a sound fアジア カジノancial base.
- Shareholder returns
- Regardアジア カジノg shareholder returns, we will contアジア カジノue stable dividends, takアジア カジノg アジア カジノto account the dividend on equity ratio (DOE).
Improve the company value according to meet high profitability by executing the medium busiアジア カジノss plan
- Maximize the ratio of アジア カジノw drugs and optimize cost competition
- Increase of R&D expenses (strengthen the drug discovery capability, expand of development pipeliアジア カジノ
- Expand capital アジア カジノvestments
- Enhance human capital